HighVista Strategies LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighVista Strategies LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2022$612,000
-58.7%
12,108
-12.5%
0.37%
-68.8%
Q4 2021$1,483,000
+13.5%
13,843
+8.9%
1.18%
+36.5%
Q3 2021$1,307,000
+68.9%
12,716
+44.4%
0.86%
+57.6%
Q2 2021$774,000
+83.8%
8,805
+63.2%
0.55%
+57.3%
Q2 2020$421,0005,3960.35%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders